Lenvatinib plus pembrolizumab versus treatment of physician's choice in patients with previously treated advanced endometrial cancer: Study 309/KEYNOTE-775 Asian subgroup Meeting Abstract
| Authors: | Yonemori, K.; Fujiwara, K.; Hasegawa, K.; Yunokawa, M.; Ushijima, K.; Suzuki, S.; Shikama, A.; Minobe, S.; Usami, T.; Kim, J. W.; Kim, B. G.; Wang, P. H.; Chang, T. C.; Yamamoto, K.; Han, S.; McKenzie, J.; Barresi, G.; Miura, T.; Makker, V.; Kim, Y. M. |
| Abstract Title: | Lenvatinib plus pembrolizumab versus treatment of physician's choice in patients with previously treated advanced endometrial cancer: Study 309/KEYNOTE-775 Asian subgroup |
| Meeting Title: | ESMO Asia Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2022 Dec 2-4 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-11-01 |
| Start Page: | S1504 |
| End Page: | S1505 |
| Language: | English |
| ACCESSION: | WOS:000897943700179 |
| DOI: | 10.1016/j.annonc.2022.10.213 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 177O -- Source: Wos |
